284 related articles for article (PubMed ID: 10853715)
1. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
2. [Hyperparathyroidism associated with hypophosphatemic osteomalacia: case report and review of the literature].
Moreira RO; Leal CT; Lacativa PG; Figueiredo JG; Lima MB; Farias ML
Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):150-5. PubMed ID: 16628288
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy.
Jeon HJ; Kwon SH; Kim SW; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
Horm Res; 2003; 60(3):127-33. PubMed ID: 12931040
[TBL] [Abstract][Full Text] [Related]
4. Tertiary hyperparathyroidism after high-dose phosphate therapy in adult-onset hypophosphatemic osteomalacia.
Younis E; Jarrah N; Sroujieh AS; Al Hadidy A; Ajlouni K
Endocr Pract; 2001; 7(5):375-8. PubMed ID: 11585374
[TBL] [Abstract][Full Text] [Related]
5. Tumor-related osteomalacia followed after treatment by hyperparathyroidism.
Heylen A; Dasnoy D; Hustin J; Pochet JM
Rev Rhum Engl Ed; 1999 Jan; 66(1):53-7. PubMed ID: 10036701
[TBL] [Abstract][Full Text] [Related]
6. Tertiary hyperparathyroidism after long-term phosphate supplementation in adult-onset hypophosphataemic osteomalacia.
Narváez J; Rodriguez-Moreno J; Moragues C; Campoy E; Clavaguera T; Roig-Escofet D
Br J Rheumatol; 1996 Jun; 35(6):598-600. PubMed ID: 8670586
[TBL] [Abstract][Full Text] [Related]
7. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases.
Firth RG; Grant CS; Riggs BL
Am J Med; 1985 Apr; 78(4):669-73. PubMed ID: 2984933
[TBL] [Abstract][Full Text] [Related]
8. [A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].
Katagiri T; Suzuki T; Akiyama Y; Ishibashi T; Hara K; Oka H; Imai T; Kobayashi K; Kitagawa H; Ohno S
Ryumachi; 1992 Oct; 32(5):461-7; discussion 466-7. PubMed ID: 1440082
[TBL] [Abstract][Full Text] [Related]
9. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
[TBL] [Abstract][Full Text] [Related]
10. A case of normocalcemic primary hyperparathyroidism with osteomalacia.
Shimada I; Inaba M; Nakano H; Miki T; Nishizawa Y; Morii H
Endocrinol Jpn; 1986 Oct; 33(5):575-82. PubMed ID: 3830067
[TBL] [Abstract][Full Text] [Related]
11. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
Sato K; Nohtomi K; Demura H; Takeuchi A; Kobayashi T; Kazama J; Ozawa H
Bone; 1997 Jul; 21(1):57-64. PubMed ID: 9213008
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
Sato K; Obara T; Yamazaki K; Kanbe M; Nakajima K; Yamada A; Yanagisawa T; Kato Y; Nishikawa T; Takano K
J Clin Endocrinol Metab; 2001 Nov; 86(11):5564-71. PubMed ID: 11701736
[TBL] [Abstract][Full Text] [Related]
13. Hypophosphatemic rickets and osteomalacia in polyostotic fibrous dysplasia.
Chattopadhyay A; Bhansali A; Mohanty SK; Khandelwal N; Mathur SK; Dash RJ
J Pediatr Endocrinol Metab; 2003; 16(6):893-6. PubMed ID: 12948303
[TBL] [Abstract][Full Text] [Related]
14. Osteomalacia in a patient with severe anorexia nervosa.
Oliveri B; Gomez Acotto C; Mautalen C
Rev Rhum Engl Ed; 1999 Oct; 66(10):505-8. PubMed ID: 10567980
[TBL] [Abstract][Full Text] [Related]
15. Primary hyperparathyroidism associated with nutritional osteomalacia.
Vaishava H; Rizvi SN
Am J Med; 1969 Apr; 46(4):640-4. PubMed ID: 5791005
[No Abstract] [Full Text] [Related]
16. [Tertiary hyperparathyroidism induced by the treatment of hypophosphatemic osteomalacia].
Vedere V; Goupille P; Valat JP; Lecomte P
Ann Endocrinol (Paris); 1996; 57(3):215-8. PubMed ID: 8949417
[TBL] [Abstract][Full Text] [Related]
17. [Hypophosphatemic osteomalacia in adults].
Löhr-Schwaab S; Wanner C; Reinbold WD; Schümichen C; Schölmerich J; Schaefer HE; Gerok W
Dtsch Med Wochenschr; 1989 Apr; 114(14):538-42. PubMed ID: 2702931
[TBL] [Abstract][Full Text] [Related]
18. Effects of tumor-induced osteomalacia on the bone mineralization process.
Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
[TBL] [Abstract][Full Text] [Related]
19. [Osteomalacia and giant cell tumor: a rare case].
Sehli H; Daoud L; Ben Mbarek R; Ghorbel R; Ben Abdelghani K; Charfi H; Cheour I; Tarhouni L; Sellami S
Tunis Med; 2008 Sep; 86(9):836-8. PubMed ID: 19472787
[TBL] [Abstract][Full Text] [Related]
20. A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.
Elston MS; Stewart IJ; Clifton-Bligh R; Conaglen JV
Bone; 2007 Jan; 40(1):236-41. PubMed ID: 16982223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]